Advanced search
Publication Cover
Acta Oncologica Volume 29, 1990 - Issue 3
Journal homepage
58
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Prediction of Objective Response to Recombinant interferon-alpha with or Without Vinblastine in Metastatic Renal Cetl Carcinoma

S. D. Fosså Departments of Medical Oncology and Radiotherapy, Pathology, and Tissue Culture, the Norwegian Radium Hospital, and Roche Norge A/S, Oslo, Norway
,
J. M. Nesland Departments of Medical Oncology and Radiotherapy, Pathology, and Tissue Culture, the Norwegian Radium Hospital, and Roche Norge A/S, Oslo, Norway
,
J. E. Melvik Departments of Medical Oncology and Radiotherapy, Pathology, and Tissue Culture, the Norwegian Radium Hospital, and Roche Norge A/S, Oslo, Norway
,
A. B. Jacobsen Departments of Medical Oncology and Radiotherapy, Pathology, and Tissue Culture, the Norwegian Radium Hospital, and Roche Norge A/S, Oslo, Norway
&
B. Moe Departments of Medical Oncology and Radiotherapy, Pathology, and Tissue Culture, the Norwegian Radium Hospital, and Roche Norge A/S, Oslo, Norway
Pages 303-306 | Accepted 21 Apr 1989, Published online: 08 Jul 2009

References

  • Cetto G L, Franceschi T, Turrina G, et al. Recombinant alpha-interferon and vinblastine in metastatic renal cell carcinoma: Efficacy of low doses. Surg Oncol 1988; 4: 184–90
  • Bergerat J-P., Herbrecht R, Dufour P, et al. Combination of recombinant interferon alpha-2A and vinblastine in advanced renal cell cancer. Cancer 1988; 62: 2320–4
  • Fosså S D, De Garis S T, Heier M S, et al. Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma. Cancer 1986; 57: 1700–4
  • Fosså S D, De Garis S T. Further experience with recombinant interferon alfa-2a with vinblastine in metastatic renal cell carcinoma: A progress report. Int J Cancer 1987, Suppl 1: 36–40
  • Fosså S D, Raabe N, Moe B. Recombinant interferon-alpha with or without vinblastine in metastatic renal cell carcinoma: Results of a randomized phase-II study. Br J Urol 1989, (In press.)
  • Krown S E. Interferon treatment of renal cell carcinoma: Current status and future prospects. Cancer 1987; 59: 647–51
  • Muss H B. Interferon therapy of metastatic renal cell cancer. Sem Surg Oncol 1988; 4: 199–203
  • Neidhart J, Harris J, Tuttle R. A randomized study of welferon (WFN) with or without vinblastine (VBL) in advanced renal cancer. Proceedings of ASCO 1987; 6: 239
  • Sarna G, Figlin R, De Kernion J. Interferon in renal cell carcinoma. The UCLA experience. Cancer 1987; 59: 610–2
  • Schornagel J, Verwey J, Bokkel Huinink W, et al. Phase-II study of recombinant interferon alpha-2 (IFN) and vinblastine (V) in advanced renal carcinoma (ARC). Proceedings of ASCO 1987; 6: 106
  • Swanson D, Quesada J R. Interferon therapy for metastatic renal cell carcinoma. Sem Surg Oncol 1988; 4: 174–7
  • Eker R, Nesland J M, Andersen A, Johannessen J V. Prognostic factors in renal cell carcinoma. Histol Histopath 1986; 1: 255–70
  • Schutte B, Reynders M MJ, Bosman F T, Blijham G H. Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 1985; 6: 26–30
  • Jacobsen A B, Fosså S D, Lunde S, Melvik J E, Pettersen E O. Comparison of DNA flow cytometry values in bladder carcinoma biopsies obtained from fresh and from paraffin-embedded material. Acta Pathol Scand (A) APMIS 1988; 96: 25–9
  • Hedley D W, Friedlander M L, Taylor I W, Rugg C A, Musgrove E A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983; 31: 1333–5
  • Vindelév L L, Christensen I J, Nissen N I. A detergent trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323–7
  • Fosså S D, Klepp O, Fjaestad K, et al. Inter- and Intra-observer variations in size evaluation of clinically measureable tumor lesions. (Abstract), 626, 13th Int Cancer Congr 1982. Seattle 1982
  • Miller A B, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–14
  • Muss H B, Costanzi J J, Leavitt R. Recombinant alpha interferon in renal cell carcinoma: A randomized trial of two routes of administration. J Clin Oncol 1987; 5: 286–91
  • Ljungberg B, Stenling R, Roos G. DNA content in renal cell carcinoma with reference to tumor heterogeneity. Cancer 1985; 56: 503–8
  • Ljungberg B, Stenling R, Roos G. DNA content and prognosis in renal cell carcinoma. A comparison between primary tumors and metastases. Cancer 1986; 57: 2346–50

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.